What are the characteristics and management of a normal ascitic fluid analysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Ascitic Fluid Analysis

Defining Normal Ascitic Fluid in Cirrhosis

In uncomplicated cirrhotic ascites, the fluid is sterile, typically clear or straw-colored, contains ≤250 polymorphonuclear cells/mm³, has a serum-ascites albumin gradient (SAAG) ≥1.1 g/dL, and total protein concentration is usually <2.5 g/dL. 1, 2

Essential Initial Testing Parameters

When performing diagnostic paracentesis on new-onset ascites, the following constitute the mandatory screening tests:

Cell Count and Differential

  • Total white blood cell count: Normal ascites contains 281 ± 25 leukocytes/mm³ (mean ± SEM) 2
  • Polymorphonuclear (PMN) cells: Should be <250 cells/mm³; 27 ± 2% of total white cells are PMN in normal ascites 2
  • PMN count ≥250 cells/mm³ indicates spontaneous bacterial peritonitis (SBP) and requires immediate empiric antibiotics 1

Serum-Ascites Albumin Gradient (SAAG)

  • SAAG ≥1.1 g/dL indicates portal hypertension with 97% accuracy 1, 3
  • Requires simultaneous measurement of serum and ascitic fluid albumin on the same day 1, 3
  • High SAAG causes include cirrhosis, cardiac ascites, Budd-Chiari syndrome, and sinusoidal obstruction syndrome 1, 3

Total Protein Concentration

  • Normal cirrhotic ascites typically has total protein <2.5 g/dL 1
  • Protein <1.5 g/dL identifies patients at high risk for developing SBP 1, 3
  • Cardiac ascites characteristically shows high SAAG with protein >2.5 g/dL, distinguishing it from cirrhotic ascites 3, 4

Gross Appearance Characteristics

The visual inspection provides immediate diagnostic clues:

  • Clear/straw-colored: Normal uncomplicated cirrhotic ascites 2
  • Turbid/cloudy: Suggests infection (SBP) or malignancy 1, 2
  • White/milky: Indicates chylous ascites with triglycerides >200 mg/dL (often >1,000 mg/dL) 1
  • Dark brown: Reflects high bilirubin from biliary tract disruption 1
  • Black: May indicate pancreatic necrosis or metastatic melanoma 1

Conditional Testing Based on Clinical Suspicion

Additional tests should be ordered only when specific diagnoses are suspected:

When to Order Culture

  • Culture at bedside in blood culture bottles if infection suspected 1, 3
  • Culture-negative neutrocytic ascites (PMN >250 cells/mm³ with negative culture) requires identical treatment to culture-positive SBP due to similar mortality 1, 3

When to Order Additional Tests

  • Cytology: For suspected malignancy (yield varies 0-96.7% depending on tumor site) 3
  • Amylase: For suspected pancreatic ascites (typically >1,000 IU/L or >6 times serum amylase) 1, 3
  • Adenosine deaminase: For suspected tuberculous peritonitis (levels <40 IU/L exclude TB with high accuracy) 1, 3
  • Gram stain, LDH, glucose: When PMN ≥250 cells/mm³ to distinguish secondary bacterial peritonitis from SBP 1

Critical Diagnostic Thresholds for Secondary Peritonitis

When PMN count ≥250 cells/mm³, order Gram stain, culture, total protein, LDH, and glucose to detect secondary bacterial peritonitis requiring surgical intervention. 1

Secondary peritonitis is suggested by:

  • Multiple organisms on Gram stain/culture 1
  • At least 2 of 3 criteria: Total protein >1 g/dL, LDH greater than upper limit of normal for serum, glucose <50 mg/dL 1
  • These criteria have 100% sensitivity but only 45% specificity for detecting perforation 1

Alternative criteria with 92% sensitivity and 88% specificity:

  • Ascitic fluid CEA >5 ng/mL OR alkaline phosphatase >240 U/L 1

Common Pitfalls to Avoid

Do Not Rely on Outdated Parameters

  • Specific gravity, protein concentration alone, and glucose level are NOT useful in differential diagnosis 2
  • Traditional exudate-transudate classification is inferior to SAAG for determining etiology 5

Do Not Order CA-125

  • CA-125 is elevated nonspecifically by ascites from any cause and has no diagnostic value 6, 3
  • Ordering CA-125 leads to unnecessary gynecologic referrals and potentially fatal surgeries 6

Do Not Assume Single Etiology

  • Approximately 5% of patients have mixed ascites with multiple contributing causes 6, 3
  • Particularly important in cirrhotic patients who develop new ascites characteristics 6

Do Not Withhold Paracentesis for Coagulopathy

  • Routine prophylactic transfusion of fresh frozen plasma or platelets before paracentesis is NOT recommended 1
  • Hemorrhage occurs in only 0.2-2.2% of punctures with death rate of 0.02% 1

When to Perform Diagnostic Paracentesis

Diagnostic paracentesis is mandatory in:

  • All patients with new-onset ascites 1, 3
  • Hospitalized cirrhotic patients with any signs of infection 3
  • Patients with gastrointestinal bleeding, hepatic encephalopathy, worsening renal/liver function 3
  • Any patient with abdominal pain, fever, or clinical deterioration 1

Follow-Up Paracentesis

Repeat paracentesis is NOT routinely needed in typical SBP cases (advanced cirrhosis, typical symptoms, single organism, dramatic clinical response) 1

Repeat paracentesis IS indicated when:

  • Setting, symptoms, analysis, or organisms are atypical 1
  • Clinical response is inadequate 1
  • Secondary peritonitis is suspected (PMN count rises despite 48 hours of appropriate antibiotics) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Analysis of ascitic fluid in cirrhosis.

Digestive diseases and sciences, 1979

Guideline

Initial Management of Ascites

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ascitic Fluid Characteristics in Nephrotic Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Low SAAG Ascites

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.